Diagnosis of MGRS in Patients With Paraproteinemias: Clinical, Anatomopathological and Pathophysiological Study (MGRS-CAPS)

A

Academia Nacional de Medicina

Status

Unknown

Conditions

Monoclonal Gammopathy of Renal Significance

Study type

Observational

Funder types

Other

Identifiers

NCT03629561
T.I. N° 12702/18/H

Details and patient eligibility

About

This is the first prospective study which evaluate patients with small B-cell clones to diagnose monoclonal gammopathy of renal significance (MGRS) and characterize it clinically, anatomopathologically and pathophysiologically taking int account a geriatric approach.

Enrollment

15 estimated patients

Sex

All

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Paraproteinemias

Exclusion criteria

  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia
  • Chronic Lymphocytic Leukemia
  • Malignant Lymphoma
  • Monoclonal gammopathy of unknown significance (MGUS) secondary to Infections
  • MGUS secondary to Autoimmune Diseases
  • Uncompleted hematological evaluation
  • Renal tumor except for cysts Bosniak type I/II
  • Other malignant neoplasia
  • Unresolved obstructive uropathy
  • Patients with only one kidney except for renal transplant
  • Co-morbidities which would limit the ability to receive aggressive therapeutic intervention
  • Fragile old people
  • Pregnancy
  • Prison
  • Impatient in psychiatric institutions.

Trial contacts and locations

1

Loading...

Central trial contact

Mariana Ciocchini, Nephrologist

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems